Some pathways have been shown to be associated with the pathological progression of triple-negative breast cancer, such as BECN1 knockout hinders tumor growth, migration, and invasion by inhibiting the cell cycle and partially inhibiting the epithelial-mesenchymal transition of human triple-negative breast cancer cells (Wu et al., 2018). This evidence concerns the gene BECN1 and triple-negative breast carcinoma.